+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Glucosamine Market by Application (Dietary Supplements, Joint Health, Skin Care), End-users (Healthcare Institutions, Home Users), Distribution Channels, Product, Consumer Demographics, Formulation Type - Global Forecast 2025-2030- Product Image
Glucosamine Market by Application (Dietary Supplements, Joint Health, Skin Care), End-users (Healthcare Institutions, Home Users), Distribution Channels, Product, Consumer Demographics, Formulation Type - Global Forecast 2025-2030- Product Image
Sale

Glucosamine Market by Application (Dietary Supplements, Joint Health, Skin Care), End-users (Healthcare Institutions, Home Users), Distribution Channels, Product, Consumer Demographics, Formulation Type - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 194 Pages
  • November 2024
  • Region: Global
  • 360iResearch™
  • ID: 5887504
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Glucosamine Market grew from USD 800.48 million in 2023 to USD 841.71 million in 2024. It is expected to continue growing at a CAGR of 5.28%, reaching USD 1.14 billion by 2030.

Glucosamine is an amino sugar primarily used for joint health and is often sourced from shellfish or synthesized artificially. Its primary function is to support cartilage formation and repair, making it a popular supplement for treating osteoarthritis and other joint-related disorders. Necessity stems from the rising geriatric population and increasing incidence of arthritis, driving demand in dietary supplements, pharmaceuticals, and functional food industries. End-use scope extends to nutraceutical formulations, beverage infusions, and fortified snacks, targeting health-conscious consumers seeking joint support benefits.

Key growth factors include an aging global population and a rising focus on preventive healthcare, which has boosted awareness and consumption of joint health supplements. Awareness about degenerative joint diseases and the need for non-surgical treatment options further support market expansion. Latest opportunities arise from formulating innovative products such as vegan glucosamine, derived from non-animal sources, catering to the expanding vegan population. Businesses could also explore glucosamine-infused cosmetics, capitalizing on its anti-inflammatory properties for skin care applications. Expansion into emerging economies, where awareness and disposable incomes are steadily increasing, presents significant growth potential.

However, limitations include the presence of substitutes like chondroitin and collagen supplements, which offer similar benefits. Regulatory hurdles due to inconsistent health claims and potential side effects pose challenges for market proliferation. Moreover, fluctuating raw material prices and supply chain disruptions, particularly for shellfish-derived glucosamine, can impact the market negatively. Best areas for innovation include research into enhanced delivery systems like slow-release capsules or liquid forms that improve absorption rates.

Additionally, collaborations with biotechnological firms could lead to breakthroughs in algae-based glucosamine production, promoting sustainability. The market exhibits moderate competition with evolving trends steering towards natural and sustainable product variations, challenging businesses to continuously innovate and differentiate their offerings to maintain competitive advantage.

Understanding Market Dynamics in the Glucosamine Market

The Glucosamine Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • How aging global populations contribute to the increasing demand for glucosamine supplements
    • Government and health organization certifications and endorsements promoting glucosamine's market acceptance
    • Increasing disposable incomes bolstering consumer ability to invest in glucosamine products for health
  • Market Restraints
    • Examining the low consumer awareness about glucosamine supplements and its effects on market demand
    • Evaluating the competition from alternative joint health supplements influencing glucosamine sales
    • Investigating the various factors that hinder the potential growth of the glucosamine market
  • Market Opportunities
    • Urbanization and sedentary lifestyles drive consumer awareness emphasizing glucosamine for joint support
    • Technological advances in glucosamine extraction lead to sustainable production and market expansion
    • Market opportunities in glucosamine-integrated cosmetics responding to consumer interest in healthy aging
  • Market Challenges
    • Navigating consumer skepticism and misconceptions about glucosamine efficacy and safety
    • Keeping up with the dynamic shifts in consumer preferences towards vegan and non-animal-based glucosamine
    • Analyzing the role of alternative supplements and complementary health products in market disruption

Exploring Porter’s Five Forces for the Glucosamine Market

Porter’s Five Forces framework further strengthens the insights of the Glucosamine Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Glucosamine Market

External macro-environmental factors deeply influence the performance of the Glucosamine Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Glucosamine Market

The Glucosamine Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Glucosamine Market

The Glucosamine Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Glucosamine Market

The Glucosamine Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Glucosamine Market, highlighting leading vendors and their innovative profiles. These include Aden Healthcare, Andra Medi Pharma India Pvt. Ltd., Bio-gen Extracts Pvt. Ltd., Captek Softgel International Inc., Cargill, Inc., Cellmark AB, Enomark Pharma, Ethical Naturals Inc., Fabrichem, Inc., Fermentis Life Sciences, GlucosaGreen, Golden Shell Pharmaceutical Co.

Ltd., Kabir Lifesciences, Koyo Chemical Co., Ltd., Lifecare Neuro Products Limited, Manus Aktteva Biopharma LLP, Panvo Organics Pvt Ltd., Pax Healthcare, Schiff Nutrition International Inc., SMPNutra, Spectrum Chemical Manufacturing Corp., TSI Health Sciences, Inc., United Laboratories, Inc., Velnex Medicare, Wellable Marine Biotech Holding Limited, and Zhejiang AOXING Biotechnology Co., Ltd.

Market Segmentation & Coverage

This research report categorizes the Glucosamine Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Application
    • Dietary Supplements
      • Capsules
      • Soft Gels
      • Tablets
    • Joint Health
      • Arthritis Relief
      • Postoperative Care
      • Sports Recovery
    • Skin Care
      • Anti-Aging Creams
      • Moisturizers
    • Veterinary Applications
      • Arthritis Treatments
      • Pet Supplements
  • End Users
    • Healthcare Institutions
      • Clinics
      • Hospitals
    • Home Users
      • Athletes
      • Elderly
      • Pregnant Women
  • Distribution Channels
    • Online Platforms
      • Direct-to-Consumer Platforms
      • Retail Websites
    • Pharmaceutical Stores
      • Chain Pharmacies
      • Independent Pharmacies
    • Specialty Nutrition Stores
      • Health Food Stores
      • Organic Stores
  • Product
    • Glucosamine Hydrochloride
      • Liquid
      • Powder
    • Glucosamine Sulfate
      • Powder
      • Tablets
    • N-Acetyl Glucosamine
      • Capsules
      • Creams
  • Consumer Demographics
    • Age Group
      • Adults
      • Seniors
      • Teenagers
    • Income Level
      • High Income
      • Low Income
      • Middle Income
    • Lifestyle
      • Active
      • Sedentary
  • Formulation Type
    • Clean Label Options
    • Non-Vegetarian
    • Vegetarian
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States (California, Florida, Illinois, New York, Ohio, Pennsylvania, Texas)
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  • Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  • Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  • Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  • Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  • Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  • What is the current size of the market, and how is it expected to grow?
  • Which products, segments, and regions present the most attractive investment opportunities?
  • What are the prevailing technology trends and regulatory factors influencing the market?
  • How do top vendors rank regarding market share and competitive positioning?
  • What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. How aging global populations contribute to the increasing demand for glucosamine supplements
5.1.1.2. Government and health organization certifications and endorsements promoting glucosamine's market acceptance
5.1.1.3. Increasing disposable incomes bolstering consumer ability to invest in glucosamine products for health
5.1.2. Restraints
5.1.2.1. Examining the low consumer awareness about glucosamine supplements and its effects on market demand
5.1.2.2. Evaluating the competition from alternative joint health supplements influencing glucosamine sales
5.1.2.3. Investigating the various factors that hinder the potential growth of the glucosamine market
5.1.3. Opportunities
5.1.3.1. Urbanization and sedentary lifestyles drive consumer awareness emphasizing glucosamine for joint support
5.1.3.2. Technological advances in glucosamine extraction lead to sustainable production and market expansion
5.1.3.3. Market opportunities in glucosamine-integrated cosmetics responding to consumer interest in healthy aging
5.1.4. Challenges
5.1.4.1. Navigating consumer skepticism and misconceptions about glucosamine efficacy and safety
5.1.4.2. Keeping up with the dynamic shifts in consumer preferences towards vegan and non-animal-based glucosamine
5.1.4.3. Analyzing the role of alternative supplements and complementary health products in market disruption
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Glucosamine Market, by Application
6.1. Introduction
6.2. Dietary Supplements
6.2.1. Capsules
6.2.2. Soft Gels
6.2.3. Tablets
6.3. Joint Health
6.3.1. Arthritis Relief
6.3.2. Postoperative Care
6.3.3. Sports Recovery
6.4. Skin Care
6.4.1. Anti-Aging Creams
6.4.2. Moisturizers
6.5. Veterinary Applications
6.5.1. Arthritis Treatments
6.5.2. Pet Supplements
7. Glucosamine Market, by End Users
7.1. Introduction
7.2. Healthcare Institutions
7.2.1. Clinics
7.2.2. Hospitals
7.3. Home Users
7.3.1. Athletes
7.3.2. Elderly
7.3.3. Pregnant Women
8. Glucosamine Market, by Distribution Channels
8.1. Introduction
8.2. Online Platforms
8.2.1. Direct-to-Consumer Platforms
8.2.2. Retail Websites
8.3. Pharmaceutical Stores
8.3.1. Chain Pharmacies
8.3.2. Independent Pharmacies
8.4. Specialty Nutrition Stores
8.4.1. Health Food Stores
8.4.2. Organic Stores
9. Glucosamine Market, by Product
9.1. Introduction
9.2. Glucosamine Hydrochloride
9.2.1. Liquid
9.2.2. Powder
9.3. Glucosamine Sulfate
9.3.1. Powder
9.3.2. Tablets
9.4. N-Acetyl Glucosamine
9.4.1. Capsules
9.4.2. Creams
10. Glucosamine Market, by Consumer Demographics
10.1. Introduction
10.2. Age Group
10.2.1. Adults
10.2.2. Seniors
10.2.3. Teenagers
10.3. Income Level
10.3.1. High Income
10.3.2. Low Income
10.3.3. Middle Income
10.4. Lifestyle
10.4.1. Active
10.4.2. Sedentary
11. Glucosamine Market, by Formulation Type
11.1. Introduction
11.2. Clean Label Options
11.3. Non-Vegetarian
11.4. Vegetarian
12. Americas Glucosamine Market
12.1. Introduction
12.2. Argentina
12.3. Brazil
12.4. Canada
12.5. Mexico
12.6. United States
13. Asia-Pacific Glucosamine Market
13.1. Introduction
13.2. Australia
13.3. China
13.4. India
13.5. Indonesia
13.6. Japan
13.7. Malaysia
13.8. Philippines
13.9. Singapore
13.10. South Korea
13.11. Taiwan
13.12. Thailand
13.13. Vietnam
14. Europe, Middle East & Africa Glucosamine Market
14.1. Introduction
14.2. Denmark
14.3. Egypt
14.4. Finland
14.5. France
14.6. Germany
14.7. Israel
14.8. Italy
14.9. Netherlands
14.10. Nigeria
14.11. Norway
14.12. Poland
14.13. Qatar
14.14. Russia
14.15. Saudi Arabia
14.16. South Africa
14.17. Spain
14.18. Sweden
14.19. Switzerland
14.20. Turkey
14.21. United Arab Emirates
14.22. United Kingdom
15. Competitive Landscape
15.1. Market Share Analysis, 2023
15.2. FPNV Positioning Matrix, 2023
15.3. Competitive Scenario Analysis
15.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. GLUCOSAMINE MARKET MULTI-CURRENCY
FIGURE 2. GLUCOSAMINE MARKET MULTI-LANGUAGE
FIGURE 3. GLUCOSAMINE MARKET RESEARCH PROCESS
FIGURE 4. GLUCOSAMINE MARKET SIZE, 2023 VS 2030
FIGURE 5. GLOBAL GLUCOSAMINE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 6. GLOBAL GLUCOSAMINE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL GLUCOSAMINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 9. GLOBAL GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL GLUCOSAMINE MARKET SIZE, BY END USERS, 2023 VS 2030 (%)
FIGURE 11. GLOBAL GLUCOSAMINE MARKET SIZE, BY END USERS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2023 VS 2030 (%)
FIGURE 13. GLOBAL GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. GLOBAL GLUCOSAMINE MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 15. GLOBAL GLUCOSAMINE MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. GLOBAL GLUCOSAMINE MARKET SIZE, BY CONSUMER DEMOGRAPHICS, 2023 VS 2030 (%)
FIGURE 17. GLOBAL GLUCOSAMINE MARKET SIZE, BY CONSUMER DEMOGRAPHICS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. GLOBAL GLUCOSAMINE MARKET SIZE, BY FORMULATION TYPE, 2023 VS 2030 (%)
FIGURE 19. GLOBAL GLUCOSAMINE MARKET SIZE, BY FORMULATION TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. AMERICAS GLUCOSAMINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 21. AMERICAS GLUCOSAMINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. UNITED STATES GLUCOSAMINE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 23. UNITED STATES GLUCOSAMINE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 24. ASIA-PACIFIC GLUCOSAMINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 25. ASIA-PACIFIC GLUCOSAMINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 26. EUROPE, MIDDLE EAST & AFRICA GLUCOSAMINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 27. EUROPE, MIDDLE EAST & AFRICA GLUCOSAMINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 28. GLUCOSAMINE MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 29. GLUCOSAMINE MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. GLUCOSAMINE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL GLUCOSAMINE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL GLUCOSAMINE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL GLUCOSAMINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLUCOSAMINE MARKET DYNAMICS
TABLE 7. GLOBAL GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL GLUCOSAMINE MARKET SIZE, BY DIETARY SUPPLEMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL GLUCOSAMINE MARKET SIZE, BY CAPSULES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL GLUCOSAMINE MARKET SIZE, BY SOFT GELS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL GLUCOSAMINE MARKET SIZE, BY TABLETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL GLUCOSAMINE MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL GLUCOSAMINE MARKET SIZE, BY JOINT HEALTH, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL GLUCOSAMINE MARKET SIZE, BY ARTHRITIS RELIEF, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL GLUCOSAMINE MARKET SIZE, BY POSTOPERATIVE CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL GLUCOSAMINE MARKET SIZE, BY SPORTS RECOVERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL GLUCOSAMINE MARKET SIZE, BY JOINT HEALTH, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL GLUCOSAMINE MARKET SIZE, BY SKIN CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL GLUCOSAMINE MARKET SIZE, BY ANTI-AGING CREAMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL GLUCOSAMINE MARKET SIZE, BY MOISTURIZERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL GLUCOSAMINE MARKET SIZE, BY SKIN CARE, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL GLUCOSAMINE MARKET SIZE, BY VETERINARY APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL GLUCOSAMINE MARKET SIZE, BY ARTHRITIS TREATMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL GLUCOSAMINE MARKET SIZE, BY PET SUPPLEMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL GLUCOSAMINE MARKET SIZE, BY VETERINARY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL GLUCOSAMINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL GLUCOSAMINE MARKET SIZE, BY HEALTHCARE INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL GLUCOSAMINE MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL GLUCOSAMINE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL GLUCOSAMINE MARKET SIZE, BY HEALTHCARE INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL GLUCOSAMINE MARKET SIZE, BY HOME USERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL GLUCOSAMINE MARKET SIZE, BY ATHLETES, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL GLUCOSAMINE MARKET SIZE, BY ELDERLY, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL GLUCOSAMINE MARKET SIZE, BY PREGNANT WOMEN, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL GLUCOSAMINE MARKET SIZE, BY HOME USERS, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL GLUCOSAMINE MARKET SIZE, BY ONLINE PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL GLUCOSAMINE MARKET SIZE, BY DIRECT-TO-CONSUMER PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL GLUCOSAMINE MARKET SIZE, BY RETAIL WEBSITES, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL GLUCOSAMINE MARKET SIZE, BY ONLINE PLATFORMS, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL GLUCOSAMINE MARKET SIZE, BY PHARMACEUTICAL STORES, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL GLUCOSAMINE MARKET SIZE, BY CHAIN PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL GLUCOSAMINE MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL GLUCOSAMINE MARKET SIZE, BY PHARMACEUTICAL STORES, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL GLUCOSAMINE MARKET SIZE, BY SPECIALTY NUTRITION STORES, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL GLUCOSAMINE MARKET SIZE, BY HEALTH FOOD STORES, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL GLUCOSAMINE MARKET SIZE, BY ORGANIC STORES, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL GLUCOSAMINE MARKET SIZE, BY SPECIALTY NUTRITION STORES, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL GLUCOSAMINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL GLUCOSAMINE MARKET SIZE, BY GLUCOSAMINE HYDROCHLORIDE, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL GLUCOSAMINE MARKET SIZE, BY LIQUID, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL GLUCOSAMINE MARKET SIZE, BY POWDER, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL GLUCOSAMINE MARKET SIZE, BY GLUCOSAMINE HYDROCHLORIDE, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL GLUCOSAMINE MARKET SIZE, BY GLUCOSAMINE SULFATE, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL GLUCOSAMINE MARKET SIZE, BY POWDER, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL GLUCOSAMINE MARKET SIZE, BY TABLETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL GLUCOSAMINE MARKET SIZE, BY GLUCOSAMINE SULFATE, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL GLUCOSAMINE MARKET SIZE, BY N-ACETYL GLUCOSAMINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL GLUCOSAMINE MARKET SIZE, BY CAPSULES, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL GLUCOSAMINE MARKET SIZE, BY CREAMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL GLUCOSAMINE MARKET SIZE, BY N-ACETYL GLUCOSAMINE, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL GLUCOSAMINE MARKET SIZE, BY CONSUMER DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL GLUCOSAMINE MARKET SIZE, BY AGE GROUP, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL GLUCOSAMINE MARKET SIZE, BY ADULTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL GLUCOSAMINE MARKET SIZE, BY SENIORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL GLUCOSAMINE MARKET SIZE, BY TEENAGERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL GLUCOSAMINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL GLUCOSAMINE MARKET SIZE, BY INCOME LEVEL, BY REGION, 2018-2030 (USD MILLION)
TABLE 69. GLOBAL GLUCOSAMINE MARKET SIZE, BY HIGH INCOME, BY REGION, 2018-2030 (USD MILLION)
TABLE 70. GLOBAL GLUCOSAMINE MARKET SIZE, BY LOW INCOME, BY REGION, 2018-2030 (USD MILLION)
TABLE 71. GLOBAL GLUCOSAMINE MARKET SIZE, BY MIDDLE INCOME, BY REGION, 2018-2030 (USD MILLION)
TABLE 72. GLOBAL GLUCOSAMINE MARKET SIZE, BY INCOME LEVEL, 2018-2030 (USD MILLION)
TABLE 73. GLOBAL GLUCOSAMINE MARKET SIZE, BY LIFESTYLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 74. GLOBAL GLUCOSAMINE MARKET SIZE, BY ACTIVE, BY REGION, 2018-2030 (USD MILLION)
TABLE 75. GLOBAL GLUCOSAMINE MARKET SIZE, BY SEDENTARY, BY REGION, 2018-2030 (USD MILLION)
TABLE 76. GLOBAL GLUCOSAMINE MARKET SIZE, BY LIFESTYLE, 2018-2030 (USD MILLION)
TABLE 77. GLOBAL GLUCOSAMINE MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 78. GLOBAL GLUCOSAMINE MARKET SIZE, BY CLEAN LABEL OPTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 79. GLOBAL GLUCOSAMINE MARKET SIZE, BY NON-VEGETARIAN, BY REGION, 2018-2030 (USD MILLION)
TABLE 80. GLOBAL GLUCOSAMINE MARKET SIZE, BY VEGETARIAN, BY REGION, 2018-2030 (USD MILLION)
TABLE 81. AMERICAS GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 82. AMERICAS GLUCOSAMINE MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 83. AMERICAS GLUCOSAMINE MARKET SIZE, BY JOINT HEALTH, 2018-2030 (USD MILLION)
TABLE 84. AMERICAS GLUCOSAMINE MARKET SIZE, BY SKIN CARE, 2018-2030 (USD MILLION)
TABLE 85. AMERICAS GLUCOSAMINE MARKET SIZE, BY VETERINARY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 86. AMERICAS GLUCOSAMINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 87. AMERICAS GLUCOSAMINE MARKET SIZE, BY HEALTHCARE INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 88. AMERICAS GLUCOSAMINE MARKET SIZE, BY HOME USERS, 2018-2030 (USD MILLION)
TABLE 89. AMERICAS GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 90. AMERICAS GLUCOSAMINE MARKET SIZE, BY ONLINE PLATFORMS, 2018-2030 (USD MILLION)
TABLE 91. AMERICAS GLUCOSAMINE MARKET SIZE, BY PHARMACEUTICAL STORES, 2018-2030 (USD MILLION)
TABLE 92. AMERICAS GLUCOSAMINE MARKET SIZE, BY SPECIALTY NUTRITION STORES, 2018-2030 (USD MILLION)
TABLE 93. AMERICAS GLUCOSAMINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 94. AMERICAS GLUCOSAMINE MARKET SIZE, BY GLUCOSAMINE HYDROCHLORIDE, 2018-2030 (USD MILLION)
TABLE 95. AMERICAS GLUCOSAMINE MARKET SIZE, BY GLUCOSAMINE SULFATE, 2018-2030 (USD MILLION)
TABLE 96. AMERICAS GLUCOSAMINE MARKET SIZE, BY N-ACETYL GLUCOSAMINE, 2018-2030 (USD MILLION)
TABLE 97. AMERICAS GLUCOSAMINE MARKET SIZE, BY CONSUMER DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 98. AMERICAS GLUCOSAMINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 99. AMERICAS GLUCOSAMINE MARKET SIZE, BY INCOME LEVEL, 2018-2030 (USD MILLION)
TABLE 100. AMERICAS GLUCOSAMINE MARKET SIZE, BY LIFESTYLE, 2018-2030 (USD MILLION)
TABLE 101. AMERICAS GLUCOSAMINE MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 102. AMERICAS GLUCOSAMINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 103. ARGENTINA GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 104. ARGENTINA GLUCOSAMINE MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 105. ARGENTINA GLUCOSAMINE MARKET SIZE, BY JOINT HEALTH, 2018-2030 (USD MILLION)
TABLE 106. ARGENTINA GLUCOSAMINE MARKET SIZE, BY SKIN CARE, 2018-2030 (USD MILLION)
TABLE 107. ARGENTINA GLUCOSAMINE MARKET SIZE, BY VETERINARY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 108. ARGENTINA GLUCOSAMINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 109. ARGENTINA GLUCOSAMINE MARKET SIZE, BY HEALTHCARE INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 110. ARGENTINA GLUCOSAMINE MARKET SIZE, BY HOME USERS, 2018-2030 (USD MILLION)
TABLE 111. ARGENTINA GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 112. ARGENTINA GLUCOSAMINE MARKET SIZE, BY ONLINE PLATFORMS, 2018-2030 (USD MILLION)
TABLE 113. ARGENTINA GLUCOSAMINE MARKET SIZE, BY PHARMACEUTICAL STORES, 2018-2030 (USD MILLION)
TABLE 114. ARGENTINA GLUCOSAMINE MARKET SIZE, BY SPECIALTY NUTRITION STORES, 2018-2030 (USD MILLION)
TABLE 115. ARGENTINA GLUCOSAMINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 116. ARGENTINA GLUCOSAMINE MARKET SIZE, BY GLUCOSAMINE HYDROCHLORIDE, 2018-2030 (USD MILLION)
TABLE 117. ARGENTINA GLUCOSAMINE MARKET SIZE, BY GLUCOSAMINE SULFATE, 2018-2030 (USD MILLION)
TABLE 118. ARGENTINA GLUCOSAMINE MARKET SIZE, BY N-ACETYL GLUCOSAMINE, 2018-2030 (USD MILLION)
TABLE 119. ARGENTINA GLUCOSAMINE MARKET SIZE, BY CONSUMER DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 120. ARGENTINA GLUCOSAMINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 121. ARGENTINA GLUCOSAMINE MARKET SIZE, BY INCOME LEVEL, 2018-2030 (USD MILLION)
TABLE 122. ARGENTINA GLUCOSAMINE MARKET SIZE, BY LIFESTYLE, 2018-2030 (USD MILLION)
TABLE 123. ARGENTINA GLUCOSAMINE MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 124. BRAZIL GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 125. BRAZIL GLUCOSAMINE MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 126. BRAZIL GLUCOSAMINE MARKET SIZE, BY JOINT HEALTH, 2018-2030 (USD MILLION)
TABLE 127. BRAZIL GLUCOSAMINE MARKET SIZE, BY SKIN CARE, 2018-2030 (USD MILLION)
TABLE 128. BRAZIL GLUCOSAMINE MARKET SIZE, BY VETERINARY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 129. BRAZIL GLUCOSAMINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 130. BRAZIL GLUCOSAMINE MARKET SIZE, BY HEALTHCARE INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 131. BRAZIL GLUCOSAMINE MARKET SIZE, BY HOME USERS, 2018-2030 (USD MILLION)
TABLE 132. BRAZIL GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 133. BRAZIL GLUCOSAMINE MARKET SIZE, BY ONLINE PLATFORMS, 2018-2030 (USD MILLION)
TABLE 134. BRAZIL GLUCOSAMINE MARKET SIZE, BY PHARMACEUTICAL STORES, 2018-2030 (USD MILLION)
TABLE 135. BRAZIL GLUCOSAMINE MARKET SIZE, BY SPECIALTY NUTRITION STORES, 2018-2030 (USD MILLION)
TABLE 136. BRAZIL GLUCOSAMINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 137. BRAZIL GLUCOSAMINE MARKET SIZE, BY GLUCOSAMINE HYDROCHLORIDE, 2018-2030 (USD MILLION)
TABLE 138. BRAZIL GLUCOSAMINE MARKET SIZE, BY GLUCOSAMINE SULFATE, 2018-2030 (USD MILLION)
TABLE 139. BRAZIL GLUCOSAMINE MARKET SIZE, BY N-ACETYL GLUCOSAMINE, 2018-2030 (USD MILLION)
TABLE 140. BRAZIL GLUCOSAMINE MARKET SIZE, BY CONSUMER DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 141. BRAZIL GLUCOSAMINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 142. BRAZIL GLUCOSAMINE MARKET SIZE, BY INCOME LEVEL, 2018-2030 (USD MILLION)
TABLE 143. BRAZIL GLUCOSAMINE MARKET SIZE, BY LIFESTYLE, 2018-2030 (USD MILLION)
TABLE 144. BRAZIL GLUCOSAMINE MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 145. CANADA GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 146. CANADA GLUCOSAMINE MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 147. CANADA GLUCOSAMINE MARKET SIZE, BY JOINT HEALTH, 2018-2030 (USD MILLION)
TABLE 148. CANADA GLUCOSAMINE MARKET SIZE, BY SKIN CARE, 2018-2030 (USD MILLION)
TABLE 149. CANADA GLUCOSAMINE MARKET SIZE, BY VETERINARY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 150. CANADA GLUCOSAMINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 151. CANADA GLUCOSAMINE MARKET SIZE, BY HEALTHCARE INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 152. CANADA GLUCOSAMINE MARKET SIZE, BY HOME USERS, 2018-2030 (USD MILLION)
TABLE 153. CANADA GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 154. CANADA GLUCOSAMINE MARKET SIZE, BY ONLINE PLATFORMS, 2018-2030 (USD MILLION)
TABLE 155. CANADA GLUCOSAMINE MARKET SIZE, BY PHARMACEUTICAL STORES, 2018-2030 (USD MILLION)
TABLE 156. CANADA GLUCOSAMINE MARKET SIZE, BY SPECIALTY NUTRITION STORES, 2018-2030 (USD MILLION)
TABLE 157. CANADA GLUCOSAMINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 158. CANADA GLUCOSAMINE MARKET SIZE, BY GLUCOSAMINE HYDROCHLORIDE, 2018-2030 (USD MILLION)
TABLE 159. CANADA GLUCOSAMINE MARKET SIZE, BY GLUCOSAMINE SULFATE, 2018-2030 (USD MILLION)
TABLE 160. CANADA GLUCOSAMINE MARKET SIZE, BY N-ACETYL GLUCOSAMINE, 2018-2030 (USD MILLION)
TABLE 161. CANADA GLUCOSAMINE MARKET SIZE, BY CONSUMER DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 162. CANADA GLUCOSAMINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 163. CANADA GLUCOSAMINE MARKET SIZE, BY INCOME LEVEL, 2018-2030 (USD MILLION)
TABLE 164. CANADA GLUCOSAMINE MARKET SIZE, BY LIFESTYLE, 2018-2030 (USD MILLION)
TABLE 165. CANADA GLUCOSAMINE MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 166. MEXICO GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 167. MEXICO GLUCOSAMINE MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 168. MEXICO GLUCOSAMINE MARKET SIZE, BY JOINT HEALTH, 2018-2030 (USD MILLION)
TABLE 169. MEXICO GLUCOSAMINE MARKET SIZE, BY SKIN CARE, 2018-2030 (USD MILLION)
TABLE 170. MEXICO GLUCOSAMINE MARKET SIZE, BY VETERINARY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 171. MEXICO GLUCOSAMINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 172. MEXICO GLUCOSAMINE MARKET SIZE, BY HEALTHCARE INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 173. MEXICO GLUCOSAMINE MARKET SIZE, BY HOME USERS, 2018-2030 (USD MILLION)
TABLE 174. MEXICO GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 175. MEXICO GLUCOSAMINE MARKET SIZE, BY ONLINE PLATFORMS, 2018-2030 (USD MILLION)
TABLE 176. MEXICO GLUCOSAMINE MARKET SIZE, BY PHARMACEUTICAL STORES, 2018-2030 (USD MILLION)
TABLE 177. MEXICO GLUCOSAMINE MARKET SIZE, BY SPECIALTY NUTRITION STORES, 2018-2030 (USD MILLION)
TABLE 178. MEXICO GLUCOSAMINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 179. MEXICO GLUCOSAMINE MARKET SIZE, BY GLUCOSAMINE HYDROCHLORIDE, 2018-2030 (USD MILLION)
TABLE 180. MEXICO GLUCOSAMINE MARKET SIZE, BY GLUCOSAMINE SULFATE, 2018-2030 (USD MILLION)
TABLE 181. MEXICO GLUCOSAMINE MARKET SIZE, BY N-ACETYL GLUCOSAMINE, 2018-2030 (USD MILLION)
TABLE 182. MEXICO GLUCOSAMINE MARKET SIZE, BY CONSUMER DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 183. MEXICO GLUCOSAMINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 184. MEXICO GLUCOSAMINE MARKET SIZE, BY INCOME LEVEL, 2018-2030 (USD MILLION)
TABLE 185. MEXICO GLUCOSAMINE MARKET SIZE, BY LIFESTYLE, 2018-2030 (USD MILLION)
TABLE 186. MEXICO GLUCOSAMINE MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 187. UNITED STATES GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 188. UNITED STATES GLUCOSAMINE MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 189. UNITED STATES GLUCOSAMINE MARKET SIZE, BY JOINT HEALTH, 2018-2030 (USD MILLION)
TABLE 190. UNITED STATES GLUCOSAMINE MARKET SIZE, BY SKIN CARE, 2018-2030 (USD MILLION)
TABLE 191. UNITED STATES GLUCOSAMINE MARKET SIZE, BY VETERINARY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 192. UNITED STATES GLUCOSAMINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 193. UNITED STATES GLUCOSAMINE MARKET SIZE, BY HEALTHCARE INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 194. UNITED STATES GLUCOSAMINE MARKET SIZE, BY HOME USERS, 2018-2030 (USD MILLION)
TABLE 195. UNITED STATES GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 196. UNITED STATES GLUCOSAMINE MARKET SIZE, BY ONLINE PLATFORMS, 2018-2030 (USD MILLION)
TABLE 197. UNITED STATES GLUCOSAMINE MARKET SIZE, BY PHARMACEUTICAL STORES, 2018-2030 (USD MILLION)
TABLE 198. UNITED STATES GLUCOSAMINE MARKET SIZE, BY SPECIALTY NUTRITION STORES, 2018-2030 (USD MILLION)
TABLE 199. UNITED STATES GLUCOSAMINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 200. UNITED STATES GLUCOSAMINE MARKET SIZE, BY GLUCOSAMINE HYDROCHLORIDE, 2018-2030 (USD MILLION)
TABLE 201. UNITED STATES GLUCOSAMINE MARKET SIZE, BY GLUCOSAMINE SULFATE, 2018-2030 (USD MILLION)
TABLE 202. UNITED STATES GLUCOSAMINE MARKET SIZE, BY N-ACETYL GLUCOSAMINE, 2018-2030 (USD MILLION)
TABLE 203. UNITED STATES GLUCOSAMINE MARKET SIZE, BY CONSUMER DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 204. UNITED STATES GLUCOSAMINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 205. UNITED STATES GLUCOSAMINE MARKET SIZE, BY INCOME LEVEL, 2018-2030 (USD MILLION)
TABLE 206. UNITED STATES GLUCOSAMINE MARKET SIZE, BY LIFESTYLE, 2018-2030 (USD MILLION)
TABLE 207. UNITED STATES GLUCOSAMINE MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 208. UNITED STATES GLUCOSAMINE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 209. ASIA-PACIFIC GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 210. ASIA-PACIFIC GLUCOSAMINE MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 211. ASIA-PACIFIC GLUCOSAMINE MARKET SIZE, BY JOINT HEALTH, 2018-2030 (USD MILLION)
TABLE 212. ASIA-PACIFIC GLUCOSAMINE MARKET SIZE, BY SKIN CARE, 2018-2030 (USD MILLION)
TABLE 213. ASIA-PACIFIC GLUCOSAMINE MARKET SIZE, BY VETERINARY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 214. ASIA-PACIFIC GLUCOSAMINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 215. ASIA-PACIFIC GLUCOSAMINE MARKET SIZE, BY HEALTHCARE INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 216. ASIA-PACIFIC GLUCOSAMINE MARKET SIZE, BY HOME USERS, 2018-2030 (USD MILLION)
TABLE 217. ASIA-PACIFIC GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 218. ASIA-PACIFIC GLUCOSAMINE MARKET SIZE, BY ONLINE PLATFORMS, 2018-2030 (USD MILLION)
TABLE 219. ASIA-PACIFIC GLUCOSAMINE MARKET SIZE, BY PHARMACEUTICAL STORES, 2018-2030 (USD MILLION)
TABLE 220. ASIA-PACIFIC GLUCOSAMINE MARKET SIZE, BY SPECIALTY NUTRITION STORES, 2018-2030 (USD MILLION)
TABLE 221. ASIA-PACIFIC GLUCOSAMINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 222. ASIA-PACIFIC GLUCOSAMINE MARKET SIZE, BY GLUCOSAMINE HYDROCHLORIDE, 2018-2030 (USD MILLION)
TABLE 223. ASIA-PACIFIC GLUCOSAMINE MARKET SIZE, BY GLUCOSAMINE SULFATE, 2018-2030 (USD MILLION)
TABLE 224. ASIA-PACIFIC GLUCOSAMINE MARKET SIZE, BY N-ACETYL GLUCOSAMINE, 2018-2030 (USD MILLION)
TABLE 225. ASIA-PACIFIC GLUCOSAMINE MARKET SIZE, BY CONSUMER DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 226. ASIA-PACIFIC GLUCOSAMINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 227. ASIA-PACIFIC GLUCOSAMINE MARKET SIZE, BY INCOME LEVEL, 2018-2030 (USD MILLION)
TABLE 228. ASIA-PACIFIC GLUCOSAMINE MARKET SIZE, BY LIFESTYLE, 2018-2030 (USD MILLION)
TABLE 229. ASIA-PACIFIC GLUCOSAMINE MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 230. ASIA-PACIFIC GLUCOSAMINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 231. AUSTRALIA GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 232. AUSTRALIA GLUCOSAMINE MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 233. AUSTRALIA GLUCOSAMINE MARKET SIZE, BY JOINT HEALTH, 2018-2030 (USD MILLION)
TABLE 234. AUSTRALIA GLUCOSAMINE MARKET SIZE, BY SKIN CARE, 2018-2030 (USD MILLION)
TABLE 235. AUSTRALIA GLUCOSAMINE MARKET SIZE, BY VETERINARY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 236. AUSTRALIA GLUCOSAMINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 237. AUSTRALIA GLUCOSAMINE MARKET SIZE, BY HEALTHCARE INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 238. AUSTRALIA GLUCOSAMINE MARKET SIZE, BY HOME USERS, 2018-2030 (USD MILLION)
TABLE 239. AUSTRALIA GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 240. AUSTRALIA GLUCOSAMINE MARKET SIZE, BY ONLINE PLATFORMS, 2018-2030 (USD MILLION)
TABLE 241. AUSTRALIA GLUCOSAMINE MARKET SIZE, BY PHARMACEUTICAL STORES, 2018-2030 (USD MILLION)
TABLE 242. AUSTRALIA GLUCOSAMINE MARKET SIZE, BY SPECIALTY NUTRITION STORES, 2018-2030 (USD MILLION)
TABLE 243. AUSTRALIA GLUCOSAMINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 244. AUSTRALIA GLUCOSAMINE MARKET SIZE, BY GLUCOSAMINE HYDROCHLORIDE, 2018-2030 (USD MILLION)
TABLE 245. AUSTRALIA GLUCOSAMINE MARKET SIZE, BY GLUCOSAMINE SULFATE, 2018-2030 (USD MILLION)
TABLE 246. AUSTRALIA GLUCOSAMINE MARKET SIZE, BY N-ACETYL GLUCOSAMINE, 2018-2030 (USD MILLION)
TABLE 247. AUSTRALIA GLUCOSAMINE MARKET SIZE, BY CONSUMER DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 248. AUSTRALIA GLUCOSAMINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 249. AUSTRALIA GLUCOSAMINE MARKET SIZE, BY INCOME LEVEL, 2018-2030 (USD MILLION)
TABLE 250. AUSTRALIA GLUCOSAMINE MARKET SIZE, BY LIFESTYLE, 2018-2030 (USD MILLION)
TABLE 251. AUSTRALIA GLUCOSAMINE MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 252. CHINA GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 253. CHINA GLUCOSAMINE MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 254. CHINA GLUCOSAMINE MARKET SIZE, BY JOINT HEALTH, 2018-2030 (USD MILLION)
TABLE 255. CHINA GLUCOSAMINE MARKET SIZE, BY SKIN CARE, 2018-2030 (USD MILLION)
TABLE 256. CHINA GLUCOSAMINE MARKET SIZE, BY VETERINARY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 257. CHINA GLUCOSAMINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 258. CHINA GLUCOSAMINE MARKET SIZE, BY HEALTHCARE INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 259. CHINA GLUCOSAMINE MARKET SIZE, BY HOME USERS, 2018-2030 (USD MILLION)
TABLE 260. CHINA GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 261. CHINA GLUCOSAMINE MARKET SIZE, BY ONLINE PLATFORMS, 2018-2030 (USD MILLION)
TABLE 262. CHINA GLUCOSAMINE MARKET SIZE, BY PHARMACEUTICAL STORES, 2018-2030 (USD MILLION)
TABLE 263. CHINA GLUCOSAMINE MARKET SIZE, BY SPECIALTY NUTRITION STORES, 2018-2030 (USD MILLION)
TABLE 264. CHINA GLUCOSAMINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 265. CHINA GLUCOSAMINE MARKET SIZE, BY GLUCOSAMINE HYDROCHLORIDE, 2018-2030 (USD MILLION)
TABLE 266. CHINA GLUCOSAMINE MARKET SIZE, BY GLUCOSAMINE SULFATE, 2018-2030 (USD MILLION)
TABLE 267. CHINA GLUCOSAMINE MARKET SIZE, BY N-ACETYL GLUCOSAMINE, 2018-2030 (USD MILLION)
TABLE 268. CHINA GLUCOSAMINE MARKET SIZE, BY CONSUMER DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 269. CHINA GLUCOSAMINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 270. CHINA GLUCOSAMINE MARKET SIZE, BY INCOME LEVEL, 2018-2030 (USD MILLION)
TABLE 271. CHINA GLUCOSAMINE MARKET SIZE, BY LIFESTYLE, 2018-2030 (USD MILLION)
TABLE 272. CHINA GLUCOSAMINE MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 273. INDIA GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 274. INDIA GLUCOSAMINE MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 275. INDIA GLUCOSAMINE MARKET SIZE, BY JOINT HEALTH, 2018-2030 (USD MILLION)
TABLE 276. INDIA GLUCOSAMINE MARKET SIZE, BY SKIN CARE, 2018-2030 (USD MILLION)
TABLE 277. INDIA GLUCOSAMINE MARKET SIZE, BY VETERINARY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 278. INDIA GLUCOSAMINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 279. INDIA GLUCOSAMINE MARKET SIZE, BY HEALTHCARE INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 280. INDIA GLUCOSAMINE MARKET SIZE, BY HOME USERS, 2018-2030 (USD MILLION)
TABLE 281. INDIA GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 282. INDIA GLUCOSAMINE MARKET SIZE, BY ONLINE PLATFORMS, 2018-2030 (USD MILLION)
TABLE 283. INDIA GLUCOSAMINE MARKET SIZE, BY PHARMACEUTICAL STORES, 2018-2030 (USD MILLION)
TABLE 284. INDIA GLUCOSAMINE MARKET SIZE, BY SPECIALTY NUTRITION STORES, 2018-2030 (USD MILLION)
TABLE 285. INDIA GLUCOSAMINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 286. INDIA GLUCOSAMINE MARKET SIZE, BY GLUCOSAMINE HYDROCHLORIDE, 2018-2030 (USD MILLION)
TABLE 287. INDIA GLUCOSAMINE MARKET SIZE, BY GLUCOSAMINE SULFATE, 2018-2030 (USD MILLION)
TABLE 288. INDIA GLUCOSAMINE MARKET SIZE, BY N-ACETYL GLUCOSAMINE, 2018-2030 (USD MILLION)
TABLE 289. INDIA GLUCOSAMINE MARKET SIZE, BY CONSUMER DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 290. INDIA GLUCOSAMINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 291. INDIA GLUCOSAMINE MARKET SIZE, BY INCOME LEVEL, 2018-2030 (USD MILLION)
TABLE 292. INDIA GLUCOSAMINE MARKET SIZE, BY LIFESTYLE, 2018-2030 (USD MILLION)
TABLE 293. INDIA GLUCOSAMINE MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 294. INDONESIA GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 295. INDONESIA GLUCOSAMINE MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 296. INDONESIA GLUCOSAMINE MARKET SIZE, BY JOINT HEALTH, 2018-2030 (USD MILLION)
TABLE 297. INDONESIA GLUCOSAMINE MARKET SIZE, BY SKIN CARE, 2018-2030 (USD MILLION)
TABLE 298. INDONESIA GLUCOSAMINE MARKET SIZE, BY VETERINARY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 299. INDONESIA GLUCOSAMINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 300. INDONESIA GLUCOSAMINE MARKET SIZE, BY HEALTHCARE INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 301. INDONESIA GLUCOSAMINE MARKET SIZE, BY HOME USERS, 2018-2030 (USD MILLION)
TABLE 302. INDONESIA GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 303. INDONESIA GLUCOSAMINE MARKET SIZE, BY ONLINE PLATFORMS, 2018-2030 (USD MILLION)
TABLE 304. INDONESIA GLUCOSAMINE MARKET SIZE, BY PHARMACEUTICAL STORES, 2018-2030 (USD MILLION)
TABLE 305. INDONESIA GLUCOSAMINE MARKET SIZE, BY SPECIALTY NUTRITION STORES, 2018-2030 (USD MILLION)
TABLE 306. INDONESIA GLUCOSAMINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 307. INDONESIA GLUCOSAMINE MARKET SIZE, BY GLUCOSAMINE HYDROCHLORIDE, 2018-2030 (USD MILLION)
TABLE 308. INDONESIA GLUCOSAMINE MARKET SIZE, BY GLUCOSAMINE SULFATE, 2018-2030 (USD MILLION)
TABLE 309. INDONESIA GLUCOSAMINE MARKET SIZE, BY N-ACETYL GLUCOSAMINE, 2018-2030 (USD MILLION)
TABLE 310. INDONESIA GLUCOSAMINE MARKET SIZE, BY CONSUMER DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 311. INDONESIA GLUCOSAMINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 312. INDONESIA GLUCOSAMINE MARKET SIZE, BY INCOME LEVEL, 2018-2030 (USD MILLION)
TABLE 313. INDONESIA GLUCOSAMINE MARKET SIZE, BY LIFESTYLE, 2018-2030 (USD MILLION)
TABLE 314. INDONESIA GLUCOSAMINE MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 315. JAPAN GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 316. JAPAN GLUCOSAMINE MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 317. JAPAN GLUCOSAMINE MARKET SIZE, BY JOINT HEALTH, 2018-2030 (USD MILLION)
TABLE 318. JAPAN GLUCOSAMINE MARKET SIZE, BY SKIN CARE, 2018-2030 (USD MILLION)
TABLE 319. JAPAN GLUCOSAMINE MARKET SIZE, BY VETERINARY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 320. JAPAN GLUCOSAMINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 321. JAPAN GLUCOSAMINE MARKET SIZE, BY HEALTHCARE INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 322. JAPAN GLUCOSAMINE MARKET SIZE, BY HOME USERS, 2018-2030 (USD MILLION)
TABLE 323. JAPAN GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 324. JAPAN GLUCOSAMINE MARKET SIZE, BY ONLINE PLATFORMS, 2018-2030 (USD MILLION)
TABLE 325. JAPAN GLUCOSAMINE MARKET SIZE, BY PHARMACEUTICAL STORES, 2018-2030 (USD MILLION)
TABLE 326. JAPAN GLUCOSAMINE MARKET SIZE, BY SPECIALTY NUTRITION STORES, 2018-2030 (USD MILLION)
TABLE 327. JAPAN GLUCOSAMINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 328. JAPAN GLUCOSAMINE MARKET SIZE, BY GLUCOSAMINE HYDROCHLORIDE, 2018-2030 (USD MILLION)
TABLE 329. JAPAN GLUCOSAMINE MARKET SIZE, BY GLUCOSAMINE SULFATE, 2018-2030 (USD MILLION)
TABLE 330. JAPAN GLUCOSAMINE MARKET SIZE, BY N-ACETYL GLUCOSAMINE, 2018-2030 (USD MILLION)
TABLE 331. JAPAN GLUCOSAMINE MARKET SIZE, BY CONSUMER DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 332. JAPAN GLUCOSAMINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 333. JAPAN GLUCOSAMINE MARKET SIZE, BY INCOME LEVEL, 2018-2030 (USD MILLION)
TABLE 334. JAPAN GLUCOSAMINE MARKET SIZE, BY LIFESTYLE, 2018-2030 (USD MILLION)
TABLE 335. JAPAN GLUCOSAMINE MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 336. MALAYSIA GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 337. MALAYSIA GLUCOSAMINE MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 338. MALAYSIA GLUCOSAMINE MARKET SIZE, BY JOINT HEALTH, 2018-2030 (USD MILLION)
TABLE 339. MALAYSIA GLUCOSAMINE MARKET SIZE, BY SKIN CARE, 2018-2030 (USD MILLION)
TABLE 340. MALAYSIA GLUCOSAMINE MARKET SIZE, BY VETERINARY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 341. MALAYSIA GLUCOSAMINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 342. MALAYSIA GLUCOSAMINE MARKET SIZE, BY HEALTHCARE INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 343. MALAYSIA GLUCOSAMINE MARKET SIZE, BY HOME USERS, 2018-2030 (USD MILLION)
TABLE 344. MALAYSIA GLUCOSAMINE MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
TABLE 345. MALAYSIA GLUCOSAMINE MARKET SIZE, BY ONLINE PLATFORMS, 2018-2030 (USD MILLION)
TABLE 346. MALAYSIA GLUCOSAMINE MARKET SIZE, BY PHARMACEUTICAL STORES, 2018-2030 (USD MILLION)
TABLE 347. MALAYSIA GLUCOSAMINE MARKET SIZE, BY SPECIALTY NUTRITION STORES, 2018-2030 (USD MILLION)
TABLE 348. MALAYSIA GLUCOSAMINE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 349. MALAYSIA GLUCOSAMINE MARKET SIZE, BY GLUCOSAMINE HYDROCHLORIDE, 2018-2030 (USD MILLION)
TABLE 350. MALAYSIA GLUCOSAMINE MARKET SIZE, BY GLUCOSAMINE SULFATE, 2018-2030 (USD MILLION)
TABLE 351. MALAYSIA GLUCOSAMINE MARKET SIZE, BY N-ACETYL GLUCOSAMINE, 2018-2030 (USD MILLION)
TABLE 352. MALAYSIA GLUCOSAMINE MARKET SIZE, BY CONSUMER DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 353. MALAYSIA GLUCOSAMINE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 354. MALAYSIA GLUCOSAMINE MARKET SIZE, BY INCOME LEVEL, 2018-2030 (USD MILLION)
TABLE 355. MALAYSIA GLUCOSAMINE MARKET SIZE, BY LIFESTYLE, 2018-2030 (USD MILLION)
TABLE 356. MALAYSIA GLUCOSAMINE MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 357. PHILIPPINES GLUCOSAMINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 358. PHILIPPINES GLUCOSAMINE MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 359. PHILIPPINES GLUCOSAMINE MARKET SIZE, BY JOINT HEALTH, 2018-2030 (USD MILLION)
TABLE 360. PHILIPPINES GLUCOSAMINE MARKET SIZE, BY SKIN CARE, 2018-2030 (USD MILLION)
TABLE 361. PHILIPPINES GLUCOSAMINE MARKET SIZE, BY VETERINARY APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 362. PHILIPPINES GLUCOSAMINE MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 363. PHILIPPINES GLUCOSAMINE MARKET SIZE, BY HEALTHCARE INSTITUTIONS, 2018-2030 (USD MILLION)
TABLE 364. PHILIPPINES GLUCOSAMINE MARKET SIZE, BY HOME USERS, 2018-2030 (USD MILLION)
TABLE 365. PHILIPPINES GLUCOSAMINE

Companies Mentioned

  • Aden Healthcare
  • Andra Medi Pharma India Pvt. Ltd.
  • Bio-gen Extracts Pvt. Ltd.
  • Captek Softgel International Inc.
  • Cargill, Inc.
  • Cellmark AB
  • Enomark Pharma
  • Ethical Naturals Inc.
  • Fabrichem, Inc.
  • Fermentis Life Sciences
  • GlucosaGreen
  • Golden Shell Pharmaceutical Co. Ltd.
  • Kabir Lifesciences
  • Koyo Chemical Co., Ltd.
  • Lifecare Neuro Products Limited
  • Manus Aktteva Biopharma LLP
  • Panvo Organics Pvt Ltd.
  • Pax Healthcare
  • Schiff Nutrition International Inc.
  • SMPNutra
  • Spectrum Chemical Manufacturing Corp.
  • TSI Health Sciences, Inc.
  • United Laboratories, Inc.
  • Velnex Medicare
  • Wellable Marine Biotech Holding Limited
  • Zhejiang AOXING Biotechnology Co., Ltd.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages194
PublishedNovember 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 841.71 million
Forecasted Market Value ( USD ) by 2030 $ 1147.62 million
Compound Annual Growth Rate5.2%
Regions CoveredGlobal
No. of Companies Mentioned26

Related Topics

Related Reports

Global Glucosamine Market Size, Share & Trends Analysis Report By Application, By Product (Glucosamine Sulfate, Glucosamine Hydrochloride, N-acetyl Glucosamine, and Others), By Regional Outlook and Forecast, 2023 - 2030 - Product Image

Global Glucosamine Market Size, Share & Trends Analysis Report By Application, By Product (Glucosamine Sulfate, Glucosamine Hydrochloride, N-acetyl Glucosamine, and Others), By Regional Outlook and Forecast, 2023 - 2030

  • Report
  • Global
From
Glucosamine - Global Strategic Business Report - Product Image

Glucosamine - Global Strategic Business Report

  • Report
  • 167 Pages
  • Global
From
Glucosamine Market Outlook Report: Industry Size, Competition, Trends and Growth Opportunities by Region, YoY Forecasts from 2024 to 2031 - Product Image

Glucosamine Market Outlook Report: Industry Size, Competition, Trends and Growth Opportunities by Region, YoY Forecasts from 2024 to 2031

  • Report
  • 144 Pages
  • Global
From
Glucosamine Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Glucosamine Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 88 Pages
  • Global
From
GNS Glucosamine Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Image

GNS Glucosamine Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • 88 Pages
  • Global
From

About the Market

Glucosamine is a naturally occurring compound found in the human body and is used in the treatment of immune disorders. It is used to reduce inflammation and pain associated with these disorders, as well as to improve joint mobility. Glucosamine is available in both oral and topical forms, and is often combined with other drugs to increase its effectiveness. It is also used in combination with other drugs to treat autoimmune diseases such as rheumatoid arthritis, lupus, and psoriasis. Glucosamine is a popular supplement for those suffering from immune disorders, as it is generally considered safe and effective. It is also widely available over the counter, making it an attractive option for those looking for an alternative to prescription medications. The glucosamine market is highly competitive, with many companies offering products that contain the compound. Some of the major players in the market include GlaxoSmithKline, Pfizer, Merck, and Novartis. Other companies that offer glucosamine products include Nature's Bounty, Schiff, and Solgar. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.